bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - ravimid hingamisteede obstruktiivsete haiguste, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - ravimid hingamisteede obstruktiivsete haiguste, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
everio airmaster annustatud inhalatsioonipulber
zentiva k.s. - salmeterool+flutikasoon - annustatud inhalatsioonipulber - 50mcg+500mcg 1annus 60annus 1tk; 50mcg+500mcg 1annus 60annus 10tk; 50mcg+500mcg 1annus 60annus 2tk
everio airmaster annustatud inhalatsioonipulber
zentiva k.s. - salmeterool+flutikasoon - annustatud inhalatsioonipulber - 50mcg+100mcg 1annus 60annus 1tk; 50mcg+100mcg 1annus 60annus 2tk; 50mcg+100mcg 1annus 60annus 10tk; 50mcg+100mcg 1annus 60annus 3tk
everio airmaster annustatud inhalatsioonipulber
zentiva k.s. - salmeterool+flutikasoon - annustatud inhalatsioonipulber - 50mcg+250mcg 1annus 60annus 3tk; 50mcg+250mcg 1annus 60annus 1tk; 50mcg+250mcg 1annus 60annus 10tk
airbufo forspiro annustatud inhalatsioonipulber
sandoz pharmaceuticals d.d. - formoterool+budesoniid - annustatud inhalatsioonipulber - 9mcg+320mcg 1mõõtannus 60mõõtannus 3tk; 9mcg+320mcg 1mõõtannus 60mõõtannus 6tk; 9mcg+320mcg 1mõõtannus 60mõõtannus 2tk
bropair spiromax
teva b.v. - salmeterol xinafoate, fluticasone propionaat - astma - ravimid hingamisteede obstruktiivsete haiguste, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
seffalair spiromax
teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - ravimid hingamisteede obstruktiivsete haiguste, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
aforbe inhalatsiooniaerosool, lahus
viatris limited - formoterool+beklometasoon - inhalatsiooniaerosool, lahus - 6mcg+100mcg 1annus 120annus 2tk; 6mcg+100mcg 1annus 120annus 1tk
anoro ellipta (previously anoro)
glaxosmithkline (ireland) limited - umeclidinium bromiid, vilanterol trifenatate - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - anoro ellipta on näidustatud hooldus bronchodilator ravi, et leevendada sümptomeid täiskasvanud patsientidel, kellel on krooniline obstruktiivne kopsuhaigus (copd).